No quarterly revenue total was found in Hypha Labs, Inc.'s SEC filings.
Hypha Labs, Inc. (FUNI) files with the SEC under industry code 8734, Services-Testing Laboratories. As of Jun 30, 2026 it held $5,110 in cash and investments and $1.8 million in total debt.
Revenue
—
Net income
$-304,757
+45.8% vs year-ago quarter
Operating cash flow
$-52,090
-123.6% vs year-ago quarter
Free cash flow
$-23,301
+30.8% vs prior quarter
EPS
$0.00
Dividend per share
None
Shares outstanding
163.90M
+12.9% vs year-ago quarter
Net cash
$-1.80M
Q3 FY2026
Operating margin
-38.1%
TTM
Company profile
- Industry
- Services-Testing Laboratories (SIC 8734)
- Listed as
- FUNI (OTC)
- Fiscal year ends
- September 30
- Incorporated in
- NV
- Headquarters
- Las Vegas, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1502966
- Former names
- Digipath, Inc. (until Mar 1, 2024); DigiPath,Inc. (until Sep 18, 2018)
Other Services-Testing Laboratories companies
- UL Solutions Inc. ULS
- Neogenomics Inc NEO
- 20/20 Biolabs, Inc. AIDX
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Jun 30, 2026 |
Q2 FY2026 Mar 31, 2026 |
Q1 FY2026 Dec 31, 2025 |
Q4 FY2025 Sep 30, 2025 |
Q3 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Operating income | -$95,953 | -$420,393 | -$475,020 | -$490,955 | -$536,027 |
| Net income | -$304,757 | -$521,114 | -$521,638 | -$558,415 | -$562,023 |
| Diluted EPS | $0.00 | $0.00 | $0.00 | -$0.00 | $0.00 |
| Operating cash flow | -$52,090 | -$50,654 | -$150,248 | -$315,063 | -$23,301 |
| Free cash flow | — | — | — | — | -$23,301 |
| Total assets | $68,327 | $159,819 | $391,601 | $409,218 | $454,103 |
| Total liabilities | $3.2M | $2.9M | $2.7M | $2.5M | $2.2M |
| Stockholders' equity | -$3.4M | -$3.1M | -$2.7M | -$2.4M | -$2.1M |
| Cash and investments | $5,110 | $82,200 | $42,854 | $38,118 | $147,192 |
| Total debt | $1.8M | $1.8M | $16,939 | $26,838 | $36,545 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Feb 17, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Auditor change
|
Jan 30, 2026 | Jan 27, 2026 |
| 10-K | Annual report | Jan 15, 2026 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 21, 2025 | Jun 30, 2025 |
All 297 Hypha Labs, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.